Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hyperlipoproteinemias
  Free Subscription

Articles published in
PLoS One
    January 2024
  1. ALBASSAM AA, Alenzi AN, Alhaqbani NK, Alhouty FK, et al
    Beliefs, awareness, use, and factors associated with herbal supplements usage among patients with chronic diseases-A cross-sectional insight from Alkharj, Saudi Arabia.
    PLoS One. 2024;19:e0295116.
    >> Share

  2. ABD RAHIM IN, Mohd Kasim NA, Omar E, Abdul Muid S, et al
    Safety evaluation of saffron extracts in early and established atherosclerotic New Zealand white rabbits.
    PLoS One. 2024;19:e0295212.
    >> Share

  3. LI Y, Gao H, Zhao J, Ma L, et al
    Safety and efficacy of bempedoic acid among patients with statin intolerance and those without: A meta-analysis and a systematic randomized controlled trial review.
    PLoS One. 2024;19:e0297854.
    >> Share

  4. XU S, Shiomi H, Yamashita Y, Koyama S, et al
    CRISPR-Cas9-guided amplification-free genomic diagnosis for familial hypercholesterolemia using nanopore sequencing.
    PLoS One. 2024;19:e0297231.
    >> Share

  5. GHANEM AS, Nemeth O, More M, Nagy AC, et al
    Role of oral health in heart and vascular health: A population-based study.
    PLoS One. 2024;19:e0301466.
    >> Share

  6. YAZDANI A, Mozaffarpur SA, Ebrahimi P, Shirafkan H, et al
    Comorbidities affecting re-admission and survival in COVID-19: Application of joint frailty model.
    PLoS One. 2024;19:e0301209.
    >> Share

    January 2023
  7. AL FARAIDY K, Akbar M, Shehri M, Aljarallah M, et al
    Multizonal observational study conducted by clinical practitioners on evolocumab use in subjects with hyperlipidemia in Saudi Arabia and Kuwait: Results from the ZERBINI study.
    PLoS One. 2023;18:e0278821.
    >> Share

  8. ALI N, Samadder M, Kathak RR, Islam F, et al
    Prevalence and factors associated with dyslipidemia in Bangladeshi adults.
    PLoS One. 2023;18:e0280672.
    >> Share

  9. AL-ASHWAL FY, Sulaiman SAS, Sheikh Ghadzi SM, Kubas MA, et al
    Physicians and pharmacists' clinical knowledge of statin therapy and monitoring parameters, and the barriers to guideline implementation in clinical practice.
    PLoS One. 2023;18:e0280432.
    >> Share

  10. ALAHMAD MM, ZainAlAbdin S, AlAhmad K, AlAhmad I, et al
    Value of the clinical pharmacist interventions in the application of the American College of Cardiology (ACC/AHA) 2018 guideline for cholesterol management.
    PLoS One. 2023;18:e0283369.
    >> Share

  11. SONG DK, Hong YS, Sung YA, Lee H, et al
    The effect of menopause on cardiovascular risk factors according to body mass index in middle-aged Korean women.
    PLoS One. 2023;18:e0283393.
    >> Share

  12. SAPKOTA BP, Baral KP, Rehfuess EA, Parhofer KG, et al
    Effects of age on non-communicable disease risk factors among Nepalese adults.
    PLoS One. 2023;18:e0281028.
    >> Share

  13. CHANG KC, Pai YW, Lin CH, Lee IT, et al
    The association between hyperlipidemia, lipid-lowering drugs and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus.
    PLoS One. 2023;18:e0287373.
    >> Share

  14. CHEN PT, Zhang HW, Tsai ZR, Peng HC, et al
    Association between hyperlipidemia and trigger finger: A nationwide population-based cohort study.
    PLoS One. 2023;18:e0288426.
    >> Share

  15. VAINSHELBOIM B, Myers J
    Dyslipidemia paradox: Analysis from the veterans exercise testing study.
    PLoS One. 2023;18:e0287923.
    >> Share

  16. HEERKENS L, van Kleef LA, de Knegt RJ, Voortman T, et al
    Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort.
    PLoS One. 2023;18:e0287467.
    >> Share

  17. COSTA S, Guerreiro J, Teixeira I, Helling DK, et al
    Patient preferences and cost-benefit of hypertension and hyperlipidemia collaborative management model between pharmacies and primary care in Portugal: A discrete choice experiment alongside a trial (USFarmacia(R)).
    PLoS One. 2023;18:e0292308.
    >> Share

  18. BADACHO AS, Mahomed OH
    Mapping evidence on barriers to and facilitators of diagnosing noncommunicable diseases (NCDs) among people living with human immunodeficiency virus (PLWH) in low- and middle-income countries (LMICs) in Africa: A scoping review protocol.
    PLoS One. 2023;18:e0294979.
    >> Share

  19. FU W, Hu F, Xu C
    Association between red blood cell distribution width/albumin ratio and all-cause mortality or cardiovascular diseases mortality in patients with diabetic retinopathy: A cohort study.
    PLoS One. 2023;18:e0296019.
    >> Share

    January 2022
  20. OPOKU E, Berisha S, Brubaker G, Robinet P, et al
    Oxidant resistant human apolipoprotein A-I functions similarly to the unmodified human isoform in delaying atherosclerosis progression and promoting atherosclerosis regression in hyperlipidemic mice.
    PLoS One. 2022;17:e0259751.
    >> Share

  21. TIAN G, Wu Y, Jin X, Zeng Z, et al
    The incidence rate and influence factors of hemolysis, lipemia, icterus in fasting serum biochemistry specimens.
    PLoS One. 2022;17:e0262748.
    >> Share

  22. WALDMANN E, Wu L, Busygina K, Altenhofer J, et al
    Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia).
    PLoS One. 2022;17:e0265838.
    >> Share

  23. WANG SK, Lee MC, Hung CL, Chen HH, et al
    Association between hypertriglyceridemic waist phenotype and hypogonadism in Taiwanese adult men.
    PLoS One. 2022;17:e0265629.
    >> Share

  24. BHATTARAI S, Bista B, Yadav BK, Gynawali P, et al
    Estimation of mean population salt intakes using spot urine samples and associations with body mass index, hypertension, raised blood sugar and hypercholesterolemia: Findings from STEPS Survey 2019, Nepal.
    PLoS One. 2022;17:e0266662.
    >> Share

  25. MCDONALD R, Kuhn K, Nguyen TB, Tannous A, et al
    A randomized clinical trial demonstrating cell type specific effects of hyperlipidemia and hyperinsulinemia on pituitary function.
    PLoS One. 2022;17:e0268323.
    >> Share

  26. ERTURK ZARARSIZ G, Bolat S, Cephe A, Kochan N, et al
    Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.
    PLoS One. 2022;17:e0263860.
    >> Share

  27. AL-ASHWAL FY, Sulaiman SAS, Sheikh Ghadzi SM, Kubas MA, et al
    Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen.
    PLoS One. 2022;17:e0269002.
    >> Share

  28. SHARMA S, Khudiwal A, Bhardwaj S, Chaturvedi H, et al
    Healthcare worker-based opportunistic screening for familial hypercholesterolemia in a low-resource setting.
    PLoS One. 2022;17:e0269605.
    >> Share

  29. EFREMOV Y, Ermolaeva A, Vladimirov G, Gordleeva S, et al
    A mathematical model of in vitro hepatocellular cholesterol and lipoprotein metabolism for hyperlipidemia therapy.
    PLoS One. 2022;17:e0264903.
    >> Share

  30. ALBUQUERQUE J, Medeiros AM, Alves AC, Bourbon M, et al
    Comparative study on the performance of different classification algorithms, combined with pre- and post-processing techniques to handle imbalanced data, in the diagnosis of adult patients with familial hypercholesterolemia.
    PLoS One. 2022;17:e0269713.
    >> Share

  31. ALI SM, Salem FE, Aboulwafa MM, Shawky RM, et al
    Hypolipidemic activity of lactic acid bacteria: Adjunct therapy for potential probiotics.
    PLoS One. 2022;17:e0269953.
    >> Share

  32. ELALEM EG, Jelani M, Khedr A, Ahmad A, et al
    Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients.
    PLoS One. 2022;17:e0260824.
    >> Share

  33. NAZLI SA, Chua YA, Mohd Kasim NA, Ismail Z, et al
    Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.
    PLoS One. 2022;17:e0273896.
    >> Share

  34. HUNG MC, Chen YY
    Association between retinitis pigmentosa and an increased risk of primary angle closure glaucoma: A population-based cohort study.
    PLoS One. 2022;17:e0274066.
    >> Share

  35. LU Z, Li Y, Li AJ, Syn WK, et al
    Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
    PLoS One. 2022;17:e0277251.
    >> Share

  36. DINTSHI M, Kone N, Khoza S
    Comparison of measured LDL cholesterol with calculated LDL-cholesterol using the Friedewald and Martin-Hopkins formulae in diabetic adults at Charlotte Maxeke Johannesburg Academic Hospital/NHLS Laboratory.
    PLoS One. 2022;17:e0277981.
    >> Share

    January 2021
  37. KIM JB, Song WH, Park JS, Youn TJ, et al
    A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
    PLoS One. 2021;16:e0245481.
    >> Share

  38. TANNOUS A, Bradford AP, Kuhn K, Fought A, et al
    A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome.
    PLoS One. 2021;16:e0247638.
    >> Share

  39. ALHABIB KF, Al-Rasadi K, Almigbal TH, Batais MA, et al
    Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
    PLoS One. 2021;16:e0251560.
    >> Share

  40. FERRARA P, Di Laura D, Cortesi PA, Mantovani LG, et al
    The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies.
    PLoS One. 2021;16:e0254631.
    >> Share

  41. FERRIERES J, Banks V, Pillas D, Giorgianni F, et al
    Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study.
    PLoS One. 2021;16:e0255345.
    >> Share

  42. EKOR M, Owusu Agyei PE, Obese E, Biney RP, et al
    Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia.
    PLoS One. 2021;16:e0247735.
    >> Share

  43. BEHBEHANI R, Ali A, Al-Moosa A
    Risk factors and visual outcome of Non-Arteritic Ischemic Optic Neuropathy (NAION): Experience of a tertiary center in Kuwait.
    PLoS One. 2021;16:e0247126.
    >> Share

  44. TRAN DT, Lekhak N, Gutierrez K, Moonie S, et al
    Risk factors associated with cardiovascular disease among adult Nevadans.
    PLoS One. 2021;16:e0247105.
    >> Share

  45. KIM JB, Song WH, Park JS, Youn TJ, et al
    Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
    PLoS One. 2021;16:e0259072.
    >> Share

  46. DE ALBUQUERQUE P, De Marco V, Vendramini THA, Amaral AR, et al
    Supplementation of omega-3 and dietary factors can influence the cholesterolemia and triglyceridemia in hyperlipidemic Schnauzer dogs: A preliminary report.
    PLoS One. 2021;16:e0258058.
    >> Share

  47. PATEL O, Muller CJF, Joubert E, Rosenkranz B, et al
    Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice.
    PLoS One. 2021;16:e0251069.
    >> Share

  48. NIGUSSIE S, Birhan N, Amare F, Mengistu G, et al
    Rate of glycemic control and associated factors among type two diabetes mellitus patients in Ethiopia: A cross sectional study.
    PLoS One. 2021;16:e0251506.
    >> Share

  49. ALSUWAILEM B, Zamzam A, Syed MH, Greco E, et al
    Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
    PLoS One. 2021;16:e0253792.
    >> Share

  50. GURZELER E, Ruotsalainen AK, Laine A, Valkama T, et al
    SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
    PLoS One. 2021;16:e0258408.
    >> Share

  51. PULIPATI VP, Amblee A, Yap SET, Shaka H, et al
    Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.
    PLoS One. 2021;16:e0260495.
    >> Share

  52. LEE Y, Shin J, Kim Y, Kim DS, et al
    Consumption of single products versus fixed-dose combination medicines for hypertension and hyperlipidemia during 2015-2019 in South Korea.
    PLoS One. 2021;16:e0259467.
    >> Share

  53. SQUIER K, Scott A, Hunt MA, Brunham LR, et al
    The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study.
    PLoS One. 2021;16:e0257269.
    >> Share

  54. LIM CY, Ho JS, Huang Z, Gao F, et al
    Public perceptions and knowledge of cholesterol management in a multi-ethnic Asian population: A population-based survey.
    PLoS One. 2021;16:e0256218.
    >> Share

  55. ALFAIFI AA, Lai L, Althemery AU
    Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework.
    PLoS One. 2021;16:e0255729.
    >> Share

  56. DESHYCKA R, Sudaryo V, Huang NJ, Xie Y, et al
    Engineered red blood cells carrying PCSK9 inhibitors persistently lower LDL and prevent obesity.
    PLoS One. 2021;16:e0259353.
    >> Share

  57. DIECI M, Llibre-Rodriguez JJ, Acosta D, Dow WH, et al
    Cuba's cardiovascular risk factors: International comparison of levels and education gradients.
    PLoS One. 2021;16:e0247831.
    >> Share

    January 2020
  58. LIU KL, Tsai WC, Tu HP, Lee CH, et al
    Statin use and the risk of chronic kidney disease in patients with psoriasis: A nationwide cohort study in Taiwan.
    PLoS One. 2020;15:e0237816.
    >> Share

  59. KIM T, Choi H, Kang J, Kim J, et al
    Association between electronic cigarette use and metabolic syndrome in the Korean general population: A nationwide population-based study.
    PLoS One. 2020;15:e0237983.
    >> Share

  60. OCHIAI M
    Evaluating the appropriate oral lipid tolerance test model for investigating plasma triglyceride elevation in mice.
    PLoS One. 2020;15:e0235875.
    >> Share

  61. KYPRIANIDOU M, Panagiotakos D, Faka A, Kambanaros M, et al
    Prevalence of multimorbidity in the Cypriot population; A cross-sectional study (2018-2019).
    PLoS One. 2020;15:e0239835.
    >> Share

  62. THOMAS R, Spence MT, Roy R, Beller E, et al
    A randomised on-line survey exploring how health condition labels affect behavioural intentions.
    PLoS One. 2020;15:e0240985.
    >> Share

  63. SINGH G, Hussain Y, Xu Z, Sholle E, et al
    Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation.
    PLoS One. 2020;15:e0239934.
    >> Share

  64. JOLL JE 2ND, Clark CR, Peters CS, Raddatz MA, et al
    Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model.
    PLoS One. 2020;15:e0238407.
    >> Share

  65. JONES LK, Sturm AC, Seaton TL, Gregor C, et al
    Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.
    PLoS One. 2020;15:e0244193.
    >> Share

  66. ZOU Y, Sheng G, Yu M, Xie G, et al
    The association between triglycerides and ectopic fat obesity: An inverted U-shaped curve.
    PLoS One. 2020;15:e0243068.
    >> Share

  67. ANANTHAKUMAR A, Liu Y, Fernandez CE, Truskey GA, et al
    Modeling statin myopathy in a human skeletal muscle microphysiological system.
    PLoS One. 2020;15:e0242422.
    >> Share

  68. PAWLOS A, Broncel M, Wlazlowska E, Jablonowska E, et al
    Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations.
    PLoS One. 2020;15:e0244675.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016